Annual CAPEX
$10.70 M
-$5.65 M-34.57%
December 31, 2023
Summary
- As of February 7, 2025, ADPT annual capital expenditures is $10.70 million, with the most recent change of -$5.65 million (-34.57%) on December 31, 2023.
- During the last 3 years, ADPT annual CAPEX has fallen by -$8.11 million (-43.11%).
- ADPT annual CAPEX is now -82.68% below its all-time high of $61.75 million, reached on December 31, 2021.
Performance
ADPT CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$344.00 K
-$1.39 M-80.10%
September 30, 2024
Summary
- As of February 7, 2025, ADPT quarterly capital expenditures is $344.00 thousand, with the most recent change of -$1.39 million (-80.10%) on September 30, 2024.
- Over the past year, ADPT quarterly CAPEX has dropped by -$954.00 thousand (-73.50%).
- ADPT quarterly CAPEX is now -98.44% below its all-time high of $22.04 million, reached on June 30, 2021.
Performance
ADPT Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$4.88 M
-$2.43 M-33.27%
September 30, 2024
Summary
- As of February 7, 2025, ADPT TTM capital expenditures is $4.88 million, with the most recent change of -$2.43 million (-33.27%) on September 30, 2024.
- Over the past year, ADPT TTM CAPEX has dropped by -$5.82 million (-54.36%).
- ADPT TTM CAPEX is now -92.11% below its all-time high of $61.87 million, reached on September 30, 2021.
Performance
ADPT TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ADPT CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.6% | -73.5% | -54.4% |
| 3 y3 years | -43.1% | -93.5% | -84.9% |
| 5 y5 years | +69.8% | -93.5% | -84.9% |
ADPT CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.7% | at low | -96.3% | at low | -92.1% | at low |
| 5 y | 5-year | -82.7% | at low | -98.4% | at low | -92.1% | at low |
| alltime | all time | -82.7% | +326.9% | -98.4% | at low | -92.1% | +721.9% |
Adaptive Biotechnologies CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $344.00 K(-80.1%) | $4.88 M(-33.3%) |
| Jun 2024 | - | $1.73 M(+14.4%) | $7.32 M(-21.2%) |
| Mar 2024 | - | $1.51 M(+16.4%) | $9.28 M(-13.2%) |
| Dec 2023 | $10.70 M(-34.6%) | $1.30 M(-53.3%) | $10.70 M(-10.4%) |
| Sep 2023 | - | $2.78 M(-24.9%) | $11.94 M(-18.2%) |
| Jun 2023 | - | $3.70 M(+26.4%) | $14.60 M(-9.9%) |
| Mar 2023 | - | $2.92 M(+15.0%) | $16.20 M(-0.9%) |
| Dec 2022 | $16.35 M(-73.5%) | $2.54 M(-53.2%) | $16.35 M(-29.1%) |
| Sep 2022 | - | $5.43 M(+2.5%) | $23.05 M(-28.5%) |
| Jun 2022 | - | $5.30 M(+72.2%) | $32.24 M(-34.2%) |
| Mar 2022 | - | $3.08 M(-66.7%) | $48.98 M(-20.7%) |
| Dec 2021 | $61.75 M | $9.24 M(-36.8%) | $61.75 M(-0.2%) |
| Sep 2021 | - | $14.62 M(-33.7%) | $61.87 M(+20.2%) |
| Jun 2021 | - | $22.04 M(+39.1%) | $51.46 M(+62.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $15.84 M(+69.1%) | $31.68 M(+68.5%) |
| Dec 2020 | $18.80 M(+67.9%) | $9.37 M(+122.7%) | $18.80 M(+58.7%) |
| Sep 2020 | - | $4.21 M(+85.9%) | $11.85 M(+7.0%) |
| Jun 2020 | - | $2.26 M(-23.6%) | $11.07 M(+7.2%) |
| Mar 2020 | - | $2.96 M(+22.6%) | $10.33 M(-7.8%) |
| Dec 2019 | $11.20 M(+77.8%) | $2.42 M(-29.6%) | $11.20 M(-0.7%) |
| Sep 2019 | - | $3.43 M(+125.2%) | $11.28 M(+12.4%) |
| Jun 2019 | - | $1.52 M(-60.2%) | $10.04 M(+5.3%) |
| Mar 2019 | - | $3.83 M(+53.5%) | $9.54 M(+51.4%) |
| Dec 2018 | $6.30 M(+151.4%) | $2.50 M(+13.9%) | $6.30 M(+65.6%) |
| Sep 2018 | - | $2.19 M(+114.7%) | $3.80 M(+135.7%) |
| Jun 2018 | - | $1.02 M(+71.7%) | $1.61 M(+171.7%) |
| Mar 2018 | - | $594.00 K | $594.00 K |
| Dec 2017 | $2.51 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual capital expenditures?
- What is the all time high annual CAPEX for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual CAPEX year-on-year change?
- What is Adaptive Biotechnologies quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly CAPEX year-on-year change?
- What is Adaptive Biotechnologies TTM capital expenditures?
- What is the all time high TTM CAPEX for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM CAPEX year-on-year change?
What is Adaptive Biotechnologies annual capital expenditures?
The current annual CAPEX of ADPT is $10.70 M
What is the all time high annual CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual capital expenditures is $61.75 M
What is Adaptive Biotechnologies annual CAPEX year-on-year change?
Over the past year, ADPT annual capital expenditures has changed by -$5.65 M (-34.57%)
What is Adaptive Biotechnologies quarterly capital expenditures?
The current quarterly CAPEX of ADPT is $344.00 K
What is the all time high quarterly CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly capital expenditures is $22.04 M
What is Adaptive Biotechnologies quarterly CAPEX year-on-year change?
Over the past year, ADPT quarterly capital expenditures has changed by -$954.00 K (-73.50%)
What is Adaptive Biotechnologies TTM capital expenditures?
The current TTM CAPEX of ADPT is $4.88 M
What is the all time high TTM CAPEX for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM capital expenditures is $61.87 M
What is Adaptive Biotechnologies TTM CAPEX year-on-year change?
Over the past year, ADPT TTM capital expenditures has changed by -$5.82 M (-54.36%)